Medicine
Clobazam 10 mg tablet
Clobazam 10 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store tablets at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Clobazam
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 cartons, 500 tablets, 10 cartons and 15 more
- Manufacturers
- Micro LabsIndiaAscend LaboratoriesIndiaCamber PharmaceuticalsIndiaLupinIndiaNovadoz PharmaceuticalsIndiaAmerican Health PackagingAmneal Pharmaceuticals NYGolden State Medical SupplyNorthStar RxLLCUpsher-Smith Laboratories
- Origin register
- US FDA, United States
- Storage
- Store tablets at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BA09 Clobazam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 October 2018
- Identifiers
- RxCUI 199450, 246172, 427538DailyMed set ID cf5bb37f-5386-47d3-8cec-d48253d359f6, 6da2c381-057b-456a-b57b-464f8b383371, cf31b8d1-0d19-4529-99b6-1f7366064a3c +7NDC 72205-047, 0832-0580, 31722-639 +7Application ANDA213404, ANDA209687, ANDA209795 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 carton in 1 container / 1 tablet in 1 carton | 67877-665-01 | Ascend LaboratoriesIndia | 7 September 2019 |
| 500 tablet in 1 container | 67877-665-05 | Ascend LaboratoriesIndia | 7 September 2019 |
| 10 carton in 1 blister pack / 1 tablet in 1 carton | 67877-665-33 | Ascend LaboratoriesIndia | 7 September 2019 |
| 100 tablet in 1 bottle | 31722-639-01 | Camber PharmaceuticalsIndia | 22 October 2018 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 31722-639-31 | Camber PharmaceuticalsIndia | 22 October 2018 |
| 1 bottle in 1 carton / 100 tablet in 1 bottle | 68180-157-01 | LupinIndia | 8 May 2019 |
| 100 tablet in 1 bottle | 42571-315-01 | Micro LabsIndia | 2 April 2019 |
| 500 tablet in 1 bottle | 42571-315-05 | Micro LabsIndia | 2 April 2019 |
| 100 blister pack in 1 carton / 10 tablet in 1 blister pack | 42571-315-11 | Micro LabsIndia | 2 April 2019 |
| 30 tablet in 1 bottle | 42571-315-30 | Micro LabsIndia | 2 April 2019 |
| 90 tablet in 1 bottle | 42571-315-90 | Micro LabsIndia | 2 April 2019 |
| 100 blister pack in 1 carton / 10 tablet in 1 blister pack | 42571-315-91 | Micro LabsIndia | 2 April 2019 |
| 1 bottle in 1 carton / 100 tablet in 1 bottle | 72205-047-91 | Novadoz PharmaceuticalsIndia | 10 June 2022 |
| 100 tablet in 1 bottle | 69238-1305-1 | Amneal Pharmaceuticals NY | 22 October 2018 |
| 100 tablet in 1 bottle | 0832-0580-11 | Upsher-Smith Laboratories | 22 October 2018 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 60687-423-21 | American Health Packaging | 17 January 2019 |
| 100 tablet in 1 bottle | 51407-585-01 | Golden State Medical Supply | 30 July 2024 |
| 100 tablet in 1 bottle | 16714-887-01 | NorthStar RxLLC | 12 November 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 October 2011 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clobazam 10 mg tablet.
Other strengths and forms of Clobazam
Clinical summary
Clobazam is a benzodiazepine indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. It is available as tablets, oral suspension and oral films. MedsAcross supplies Clobazam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClobazamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Onfi prescribing information (Lundbeck Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Clobazam 10 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.